查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1179897

2023-2030 年全球血管造影设备市场

Global Angiography Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内 (2023-2030)，血管造影设备的全球市场规模预计将以 6.2% 的复合年增长率增长。

血管造影系统是一种医学成像设备，可以显示体内血管和器官的内部（管腔），特别关注动脉、静脉和心室。 包括血管造影系统、导管、导丝、球囊、造影剂、血管闭合装置、血管造影配件等。

市场动态

心血管疾病病例的增加、老年人口的增加、生活方式的改变、心血管疾病意识的提高以及市场开发预计将推动全球血管造影设备市场的增长。.

新产品的发布将在预测期内推动全球血管造影设备市场。

血管造影新产品的推出将在预测期内推动全球血管造影设备市场。 例如，在 , 2020 年北美放射学会 (RSNA) 虚拟会议上，GE Healthcare 推出了 Allia IGS 7 血管造影系统。 该系统利用人工智能来扩大旋转血管造影的使用。 同样在 2021 年 11 月，Philips通过为其 Hybrid AngioCT 套件配备突破性的光谱 CT 成像技术，展示了其对介入医学的认识。 通过将公司专有的 Spectral CT 7500 系统和图像引导治疗系统 Azurion 和 FlexArm 集成到一个单一的介入套件解决方案中，Philips将为介入医师提供对这两种重要成像模式的即时访问。我希望能够访问 .

此外，2022 年 4 月，GE Healthcare 推出了 Discovery IGS 740 移动血管造影系统。 不受束缚的 Discovery IGS 740 提供出色的房间设计和坐姿灵活性。 Discovery 的无轨设计和可调节的宽孔 C 形臂定位为医生提供了卓越的舒适性和控制力。 此外，大型探测器涵盖了广泛的 2D 和 3D 解剖结构。 同样，2022 年 11 月，Genesis Metec Group 宣布推出 TriReme Medical LLC 设计的巧克力触感药物涂层球囊 PTA 导管，用于治疗股浅动脉和腘动脉外周动脉疾病患者。FDA（食品和药物）行政）批准。 因此，上述数据表明，在预测期内，产品推出的增加将推动全球血管造影设备的增长。

严格的法规和高成本阻碍了全球血管造影设备市场的增长。

但是，主要市场参与者经常从市场召回产品，这限制了预测期内全球血管造影设备的增长。 例如，2021 年 7 月，美敦力 (Medtronic) 发现了 54,997 件召回的 pc，其中在血管造影期间用于将导管引入血管的导丝组件在运往医院之前未经过消毒。 此外，2021 年 9 月，Cordis 召回了带有不透射线标记带的 SUPER TORQUE MB 血管造影导管，原因是标记带可能发生迁移或误插入。 FDA 将其归类为 I 类，即最严重的召回。

COVID-19 影响分析

COVID-19 大流行对全球血管造影市场产生了负面影响。 因为在大流行期间，血管造影手术明显减少。 例如，英国心血管介入学会对大流行关闭期间在英国进行的所有经皮冠状动脉介入治疗 (PCI) 与大流行前 PCI 进行了回顾性比较，并进行了分析。 结果，PCI 减少了 49%，其中稳定型心绞痛减少了 66%，ST 段抬高 MI (STEMI) 的 PCI 减少了 33%。 此外，大流行病对全球血管造影设备产生了负面影响，因为它改变了人们对健康生活方式的看法并减少了心血管疾病病例数。

内容

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 心血管疾病增加
      • 老年人口增加
      • 市场策略
    • 约束因素
      • 产品市场召回
      • 严格监管
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 血管造影系统
  • 导管
  • 导丝
  • 气球
  • 造影剂
  • 血管闭合装置
  • 血管造影配件

第 8 章按应用程序类型

  • 诊断
  • 治疗

第 9 章按技术类型

  • X光
  • 核磁共振
  • CT

第 10 章技术

  • 冠状动脉
  • 血管内治疗
  • 神经血管

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准

第13章公司简介

  • Medtronic Plc
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Abbott
  • Boston Scientific Corporation
  • Teleflex Incorporated
  • B.Barun Melsungen
  • Siemens Healthineers
  • Lepu Medical
  • GE Healthcare
  • Haemonetics Corporation
  • Cook Medical Inc.

第14章数据M

简介目录
Product Code: DMMD1651

Market Overview

The global angiography devices market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 6.2% during the forecast period (2023-2030).

Angiography devices are medical imaging devices used to visualize the inside, or lumen, of blood vessels and organs of the body, with a particular interest in the arteries, veins, and heart chambers. These include Angiography Systems, Catheters, Guidewires, Balloons, Contrast Media, Vascular Closure Devices, and Angiography Accessories.

Market Dynamics

The rising cases of cardiovascular diseases, growing geriatric populations, lifestyle changes, increasing awareness about cardiovascular diseases, and market developments are expected to fuel the global angiography devices market growth.

The new product launches boost the global angiography devices market during the forecast period.

The new product introduction for angiography boosts the global angiography devices market during the forecast period. For instance, in the Radiological Society of North America (RSNA) virtual meeting in 2020, GE Healthcare revealed its Allia IGS 7 angiography system. The system utilizes artificial intelligence to amplify the use of rotational angiography. Also, in November 2021, Royal Philips disclosed its perception of interventional medicine by including its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. Philips expects to deliver interventionalists instantaneous table-side access to these two key imaging modalities by integrating the company's unique Spectral CT 7500 system and its Image-Guided Therapy System, Azurion, with FlexArm in a single interventional suite solution.

Additionally, in April 2022, GE Healthcare launched its Discovery IGS 740 mobile angiography system. The untethered Discovery IGS 740 delivers excellent room design and sitting flexibility. The Discovery's rail-free design and adjustable wide-bore C-arm positioning deliver exceptional comfort and control to the practitioners. Moreover, its large detector covers extensive anatomies in both 2D and 3D. Likewise, in November 2022, Genesis MedTech Group received the Food and Drug Administration (FDA) approval for its Chocolate Touch Drug-coated Balloon PTA Catheter, designed by TriReme Medical LLC, indicated for the treatment of patients with peripheral artery disease in the superficial femoral artery and the popliteal artery. Thus, the mentioned data indicates that the increasing product introductions drive the growth of global angiography devices in the forecasted period.

The stringent regulations and high costs hinder the global angiography devices market growth.

However, the reoccurring product recalls from the market by key market players are restraining the growth of global angiography devices during the forecasted period. For instance, in July 2021, Medtronic's recalled 54,997 guidewire components used during angiography to place catheters into the vascular system because the devices were not sterilized before being shipped to hospitals. Also, in September 2021, Cordis Recalled its SUPER TORQUE MB angiographic catheter with radiopaque marker bands due to the potential for marker bands to move or mislodge. The FDA has recognized this as a Class I recall, the most serious recall.

COVID-19 Impact Analysis

The COVID-19 pandemic had a negative impact on the global Angiography Devices market since, during the pandemic, there was a large downfall in Angiography procedures. For instance, the British Cardiovascular Interventional society performed a retrospective analysis of all percutaneous coronary interventions (PCI) performed in the United Kingdom during the lockdown imposed by the pandemic in comparison with PCI volumes in the pre-pandemic period. The retrospective analysis concluded that there was 49% less PCI, with stable angina being hit the hardest, showing a 66% reduction, while the PCI for ST-elevation MI (STEMI) was down by 33%. Furthermore, the pandemic changed people's perspective toward healthy lifestyle choices, which caused a reduction in the cases of cardiovascular diseases, therefore impacting global angiography devices negatively.

Segment Analysis

Coronary heart disease is predicted to have a high demand during the forecast period (2022-2029).

Coronary heart disease is a heart disease in which the heart's arteries are unable to deliver sufficiently oxygen-rich blood to the heart muscles. It is the top reason for death. The reason for coronary heart disease relies on the type. Coronary artery disease is usually induced by cholesterol, a waxy substance that assembles up inside the lining of the coronary arteries, creating plaque. This buildup can partly or completely block blood flow in the heart's large arteries. The coronary microvascular condition occurs when the heart's tiny blood vessels do not typically work. For most individuals, coronary heart disease is preventable with a heart-healthy lifestyle.

Since the number of coronary heart disease cases is growing, coronary angiography is estimated to dominate the global angiography devices market throughout the forecast period. For instance, the American Heart Association estimated that globally, 244.1 million people were living with ischemic heart disease (IHD) in 2020, and it was more dominant in males than in females (141.0 and 103.1 million people, respectively). The highest prevalence rates of IHD were in North Africa and the Middle East, Central and South Asia, and Eastern Europe, and IHD mortality rates were highest in North Africa, the Middle East, Eastern Europe, and Central Asia in 2020. Thus, the mentioned data indicates that coronary angiography will dominate the global angiography devices market during the forecast period.

Geographical Analysis

North America is predicted to command the global angiography devices market.

North America is estimated to hold a large market over the forecast period (2022-2029) because of the growing cases of cardiovascular conditions and the existence of key market players in this region. For instance, according to the CDC, a U.S. American dies every 34 seconds because of cardiovascular disease. Cardiovascular disease caused over 697,000 deaths in 2020. Moreover, the existence of key market players such as Abbott, Haemonetics Corporation, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, and Cook Medical Inc., having considerable percentages of the global angiography devices market through different market strategies, are based in the United States, secures the dominance of this region over the global angiography devices market. For instance, in May 2022, Teleflex Incorporated, a leading global medical technology provider, was granted Health Canada approval for its MANTA Vascular Closure Device, the first commercially available biomechanical vascular closure device developed particularly for large bore femoral arterial access site closure. This approval marks an essential landmark in the regulatory strategy to extend the availability of the MANTA Device globally and delivers access to another uniquely developed device from Teleflex to Canadian clinicians.

Also, in January 2021, Haemonetics Corporation ("Haemonetics"), a global medical technology company concentrated on delivering inventive medical solutions to drive better patient outcomes, acquired a privately-held Cardiva Medical, Inc. ("Cardiva"), an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Haemonetics enhances its penetration into the large and growing interventional cardiology and electrophysiology markets with this acquisition. Therefore, the data indicate that North America Holds most of the global market.

Competitive Landscape

The major global angiography devices market players are Abbott, Boston Scientific Corporation, Teleflex Incorporated, Medtronic, B.Barun Melsungen, Siemens Healthineers, Lepu Medical, GE Healthcare, Haemonetics Corporation, and Cook Medical Inc. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the Angiography Devices market globally. For instance, in October 2022, Lepu Medical obtained the MDR certificate issued by the BSI Netherlands Notified Body (2797) for its Ultraskin Hydrophilic Guide Wire and approved it for sale in the EU market. The certificate is valid for five years. Ultraskin Hydrophilic Guide Wire is the second product of Lepu Medical's high-risk class III product certified under MDR.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

The product portfolio of Medtronic, Plc. for angiography devices contains Launcher: A coronary guide catheter comes with the performance advantages expected from a market leader, including a wide variety of curve shapes for transradial and femoral percutaneous coronary intervention (PCI).

The global angiography devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Growing Prevalence of Cardio-vascular diseases
      • 4.1.1.2. Growing Geriatric Population
      • 4.1.1.3. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Product Market Recalls
      • 4.1.2.2. Stringent Regulation
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Angiography Systems
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Catheters
  • 7.4. Guidewires
  • 7.5. Balloons
  • 7.6. Contrast Media
  • 7.7. Vascular Closure Devices
  • 7.8. Angiography Accessories

8. By Application Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 8.1.2. Market Attractiveness Index, By Application Type
  • 8.2. Diagnostic
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Therapeutic

9. By Technology Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 9.1.2. Market Attractiveness Index, By Technology Type
  • 9.2. X-Ray
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. MRI
  • 9.4. CT

10. By Procedure

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.1.2. Market Attractiveness Index, By Procedure
  • 10.2. Coronary
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Endovascular
  • 10.4. Neurovascular

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology Type
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Abbott
  • 13.3. Boston Scientific Corporation
  • 13.4. Teleflex Incorporated
  • 13.5. B.Barun Melsungen
  • 13.6. Siemens Healthineers
  • 13.7. Lepu Medical
  • 13.8. GE Healthcare
  • 13.9. Haemonetics Corporation
  • 13.10. Cook Medical Inc.

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us